Subtle Myocardial Deformation Abnormalities in Asymptomatic Nf-1 Patients
NCT ID: NCT02505412
Last Updated: 2015-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2015-10-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
NCT02922517
Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy
NCT06169358
Cardiac Amyloidosis in HFpEF
NCT04587648
Identification of Prognostic Parameters in Patients With " Senile " Amyloid Cardiomyopathy
NCT04225754
Diffuse Myocardial Fibrosis in Fontan Patients
NCT01929174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 0-17y and 11 months
Exclusion Criteria
* history of cardiovascular disease
* chronic renal insufficiency
1 Day
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
michal roll
michal roll (telavivsmo)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TLV-0212-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.